Medical Pharmacology: Gastrointestinal Pharmacology Practice Questions
Choose the correct answer for each question.
Use of bismuth in management of
Helicobacter Pylorii associated peptic ulcer disease:
- Combination treatment: proton pump inhibitor + bismuth subsalicylate + tetracycline + metronidazole.
- Combination treatment: proton pump inhibitor + combination formulation containing bismuth, metronidazole, and tetracycline.
- Both
- Neither
Bismuth formulations:
- May cause blackening of the stools (harmless)
- Should be likely avoided in patients with renal insufficiency.
- Both
- Neither
Rare bismuth toxicity associated with prolonged use:
- Headache
- Seizures
- Confusion
- Ataxia
- A & B
- B & C
- A, B & C
- A, B, C & D (all the symptoms apply)
Muscarinic receptor (M1) blocker(s) shown to decrease baseline acid production by about half.
- Telenzepine
- Pirenzepine (Gastrozepin)
- Both
- Neither
Pirenzepine has been associated with an elevated risk of blood disorders.
- True
- False
|
If you wish to return to the Table of Contents
in ENGLISH, press the RETURN button above. |
|
Otherwise, if the text is NOT displayed in
English and you are ready to leave this page,
Press here
to return to the Table of Contents
 |
